OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Coronavirus Disease 2019 Messenger RNA Vaccines Associated With Delayed Onset of Breakthrough Infections and Fewer Radiographic Abnormalities
Xin Li, Jacky Man Chun Chan, Bosco Lam, et al.
Clinical Infectious Diseases (2022) Vol. 75, Iss. 1, pp. e905-e908
Open Access | Times Cited: 6
Xin Li, Jacky Man Chun Chan, Bosco Lam, et al.
Clinical Infectious Diseases (2022) Vol. 75, Iss. 1, pp. e905-e908
Open Access | Times Cited: 6
Showing 6 citing articles:
Kinetics of the Neutralizing and Spike SARS-CoV-2 Antibodies following the Sinovac Inactivated Virus Vaccine Compared to the Pfizer mRNA Vaccine in Singapore
Chin Shern Lau, May Lin Helen Oh, Soon Kieng Phua, et al.
Antibodies (2022) Vol. 11, Iss. 2, pp. 38-38
Open Access | Times Cited: 13
Chin Shern Lau, May Lin Helen Oh, Soon Kieng Phua, et al.
Antibodies (2022) Vol. 11, Iss. 2, pp. 38-38
Open Access | Times Cited: 13
Survey among Italian experts on existing vaccines’ role in limiting antibiotic resistance
Federico Marchetti, Rosa Prato, Pierluigi Viale
Human Vaccines & Immunotherapeutics (2021) Vol. 17, Iss. 11, pp. 4283-4290
Open Access | Times Cited: 7
Federico Marchetti, Rosa Prato, Pierluigi Viale
Human Vaccines & Immunotherapeutics (2021) Vol. 17, Iss. 11, pp. 4283-4290
Open Access | Times Cited: 7
The Epidemiological, Clinical Features and Outcomes of Imported Chinese COVID-19 Patients Following Inactivated Vaccines Injection
Jianwu Li, Na Jiang, Qing‐Lei Zeng, et al.
Infection and Drug Resistance (2022) Vol. Volume 15, pp. 2115-2125
Open Access | Times Cited: 4
Jianwu Li, Na Jiang, Qing‐Lei Zeng, et al.
Infection and Drug Resistance (2022) Vol. Volume 15, pp. 2115-2125
Open Access | Times Cited: 4
Clinical outcomes and risk factors for SARS-CoV-2 breakthrough cases following vaccination with BNT162b2, CoronaVac, or ChAdOx1-S: A retrospective cohort study in Malaysia
Hessa Tamim, Rosnani Hashim, Nurdiana Jamil, et al.
Heliyon (2024) Vol. 10, Iss. 8, pp. e29574-e29574
Open Access
Hessa Tamim, Rosnani Hashim, Nurdiana Jamil, et al.
Heliyon (2024) Vol. 10, Iss. 8, pp. e29574-e29574
Open Access
Disease Severity in Vaccinated Adults Hospitalized with Breakthrough COVID-19
Arkadiy Finn, Vijairam Selvaraj, Atin Jindal, et al.
Hospital Topics (2022) Vol. 102, Iss. 4, pp. 223-230
Closed Access
Arkadiy Finn, Vijairam Selvaraj, Atin Jindal, et al.
Hospital Topics (2022) Vol. 102, Iss. 4, pp. 223-230
Closed Access
